Physician profile
Claudia Irmiere
NPI 1588815906
$1,219.66
in general payments reported to CMS, 2019-2025
12 companies · $341 in 2025
The $341 reported for 2025 was more than what 92% of Critical Care Medicine (Registered Nurse) providers received nationally (typical 2025 total: $51.32).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.40 · 2022: $124 · 2023: $210 · 2024: $515 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $325.83 | 2023-2025 | Watchman Flx, Watchman Access System, Emblem Mri S-Icd |
| Abbott Laboratories | $197.44 | 2024-2025 | Navitor, Diamondback Coronary, Na |
| Edwards Lifesciences Corporation | $173.88 | 2022-2024 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.80 | 2024 | Lifevest |
| Biosense Webster, INC. | $83.88 | 2024 | Octaray Mapping Catheter, Carto 3, Nuvision Ice Catheter |
| E.R. Squibb & Sons, L.L.C. | $78.23 | 2021-2024 | Camzyos |
| Medtronic, INC. | $73.01 | 2025 | Micra |
| Amgen INC. | $58.97 | 2021-2022 | |
| Pfizer INC. | $37.27 | 2025 | |
| Novo Nordisk INC | $31.08 | 2023 | Ozempic, Rybelsus |
| Shockwave Medical, INC | $30.27 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Irmiere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.